|
AP646A
(en)
*
|
1995-03-27 |
1998-04-27 |
Sanofi Synthelabo |
Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections.
|
|
EP0944382A1
(en)
*
|
1996-09-30 |
1999-09-29 |
Brigham & Women's Hospital |
Methods and compounds for treatment of abnormal uterine bleeding
|
|
CA2307792C
(en)
*
|
1997-10-31 |
2007-06-26 |
Children's Medical Center Corporation |
Method for regulating size and growth of vascularized normal tissue
|
|
EP1119371B1
(en)
*
|
1998-10-09 |
2010-11-24 |
Vegenics Limited |
Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY
|
|
US7141607B1
(en)
*
|
2000-03-10 |
2006-11-28 |
Insite Vision Incorporated |
Methods and compositions for treating and inhibiting retinal neovascularization
|
|
JPWO2004022082A1
(ja)
*
|
2002-09-04 |
2005-12-22 |
株式会社プロテイン・エクスプレス |
胚着床制御剤
|
|
US20040266688A1
(en)
*
|
2003-05-14 |
2004-12-30 |
Nayak Nihar R |
Methods for modulating endometrium
|
|
US20070213126A1
(en)
*
|
2003-07-14 |
2007-09-13 |
Fusion Sport International Pty Ltd |
Sports Training And Testing Methods, Appartaus And System
|
|
US7524811B2
(en)
*
|
2003-08-29 |
2009-04-28 |
Children's Medical Center Corporation |
Anti-angiogenic peptides from the N-terminus of endostatin
|
|
AU2004269399A1
(en)
*
|
2003-08-29 |
2005-03-10 |
Children's Medical Center Corporation |
Anti-angiogenic peptides from the N-terminus of endostatin
|
|
EP2285989B1
(en)
|
2008-05-15 |
2016-11-16 |
The University of North Carolina At Chapel Hill |
Novel targets for regulation of angiogenesis
|
|
EP2140860A1
(en)
*
|
2008-07-03 |
2010-01-06 |
Bayer Schering Pharma Oy |
An improved method of contraception
|
|
EP2317845A4
(en)
*
|
2008-07-18 |
2011-11-09 |
Zafgen Inc |
METHOD FOR TREATING AN OVERWEIGHT OR FATABLE PERSON
|
|
US20100159506A1
(en)
*
|
2008-07-25 |
2010-06-24 |
Cellscape Corporation |
Methods and systems for genetic analysis of fetal nucleated red blood cells
|
|
US8642650B2
(en)
|
2008-12-04 |
2014-02-04 |
Zafgen, Inc. |
Methods of treating an overweight or obese subject
|
|
WO2010065877A2
(en)
|
2008-12-04 |
2010-06-10 |
Zafgen Corporation |
Methods of treating an overweight or obese subject
|
|
AU2010303270A1
(en)
|
2009-10-09 |
2012-05-03 |
Zafgen Corporation |
Sulphone compounds for use in the treatment of obesity
|
|
US8772333B2
(en)
|
2010-01-08 |
2014-07-08 |
Zafgen, Inc. |
Fumigillol type compounds and methods of making and using same
|
|
WO2011085198A1
(en)
|
2010-01-08 |
2011-07-14 |
Zafgen Corporation |
Metap-2 inhibitor for use in treating benign prostatic hypertrophy (bph)
|
|
RU2427325C1
(ru)
*
|
2010-01-29 |
2011-08-27 |
Государственное образовательное учреждение высшего профессионального образования "Астраханская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО АГМА Росздрава) |
Способ оценки эффективности лечения хронической плацентарной недостаточности в эксперименте
|
|
US8774488B2
(en)
|
2010-03-11 |
2014-07-08 |
Cellscape Corporation |
Method and device for identification of nucleated red blood cells from a maternal blood sample
|
|
US20130266578A1
(en)
|
2010-04-07 |
2013-10-10 |
Thomas E. Hughes |
Methods of treating an overweight subject
|
|
CN103079567A
(zh)
|
2010-04-17 |
2013-05-01 |
拜尔健康护理有限责任公司 |
用于疾病和病症的治疗和预防的氟取代的ω-羧基芳基二苯脲的合成代谢产物
|
|
CA2805874A1
(en)
|
2010-07-19 |
2012-01-26 |
Bayer Healthcare Llc |
Drug combinations with fluoro-substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
|
|
US9266896B2
(en)
|
2010-07-22 |
2016-02-23 |
Zafgen, Inc. |
Tricyclic compounds and methods of making and using same
|
|
PH12013500934A1
(en)
|
2010-11-09 |
2022-10-24 |
Zafgen Inc |
Crystalline solids of a metap-2 inhibitor and methods of making and using same
|
|
WO2012075020A1
(en)
|
2010-11-29 |
2012-06-07 |
Zafgen Corporation |
Treatment of obesity using non-daily administration of 6 - 0 - (4 - dimethylaminoethoxy) cinnamoyl fumagillol
|
|
MX344238B
(es)
|
2011-01-26 |
2016-12-07 |
Zafgen Inc |
Compuestos de tetrazol y métodos para preparar y usar los mismos.
|
|
MX342257B
(es)
|
2011-03-08 |
2016-09-21 |
Zafgen Inc |
Derivados y análogos de oxaspiro [2.5] octano.
|
|
EP2705030B1
(en)
|
2011-05-06 |
2016-07-27 |
Zafgen, Inc. |
Partially saturated tricyclic compounds and methods of making and using same
|
|
US9187494B2
(en)
|
2011-05-06 |
2015-11-17 |
Zafgen, Inc. |
Aryl-substituted tricyclic sulfonamides as methionyl aminopeptidase 2 modulators
|
|
MX343688B
(es)
|
2011-05-06 |
2016-11-16 |
Zafgen Inc |
Compuestos tricíclicos de sulfonamida y pirazolo y métodos para su fabricación y uso.
|
|
EP2763671A2
(en)
|
2011-10-03 |
2014-08-13 |
Zafgen, Inc. |
Methods of treating age related disorders
|
|
JP6035347B2
(ja)
|
2012-01-18 |
2016-11-30 |
ザフゲン，インコーポレイテッド |
三環式スルホンアミド化合物ならびにその作製および使用方法
|
|
AU2013209719A1
(en)
|
2012-01-18 |
2014-08-07 |
Zafgen, Inc. |
Tricyclic sulfone compounds and methods of making and using same
|
|
AU2013259760A1
(en)
|
2012-05-07 |
2014-11-20 |
Zafgen, Inc. |
Polymorphic salt of the oxalate salt of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol and methods of making and using same
|
|
CN104363905A
(zh)
|
2012-05-08 |
2015-02-18 |
扎夫根股份有限公司 |
用metap2抑制剂治疗下丘脑性肥胖
|
|
BR112014027981A2
(pt)
|
2012-05-09 |
2017-06-27 |
Zafgen Inc |
compostos do tipo fumagilol e métodos de produção e utilização dos mesmos
|
|
CA2890344A1
(en)
|
2012-11-05 |
2014-05-08 |
Zafgen, Inc. |
Tricyclic compounds for use in the treatment and/or control of obesity
|
|
EA028367B1
(ru)
|
2012-11-05 |
2017-11-30 |
Зафджен, Инк. |
Способы лечения заболеваний печени
|
|
BR112015010225A2
(pt)
|
2012-11-05 |
2017-07-11 |
Zafgen Inc |
compostos tricíclicos e seus métodos de produção e utilização
|
|
US9597309B2
(en)
|
2013-03-14 |
2017-03-21 |
Zafgen, Inc. |
Methods of treating renal disease and other disorders
|
|
AR105671A1
(es)
|
2015-08-11 |
2017-10-25 |
Zafgen Inc |
Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
|
|
CN106432255A
(zh)
|
2015-08-11 |
2017-02-22 |
扎夫根公司 |
烟曲霉素醇螺环化合物和制备和使用其的方法
|